Patents Assigned to Aerpio Therapeutics Inc.
  • HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
    Publication number: 20130096140
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: December 1, 2012
    Publication date: April 18, 2013
    Applicant: Aerpio Therapeutics Inc.
    Inventor: Aerpio Therapeutics Inc.
  • Treatment of Ocular Disease
    Publication number: 20130095105
    Abstract: Disclosed are methods for treating eye diseases or conditions characterized by vascular instability, vascular leakage and neovacularization such as diabetic macular edema, age-related macular edema, choroidal neovascularization, diabetic retinopathy, trauma, ocular ischemia, retinal angiomatous proliferation, macular telangiectasia and uveitis.
    Type: Application
    Filed: October 15, 2012
    Publication date: April 18, 2013
    Applicant: AERPIO THERAPEUTICS, INC.
    Inventor: AERPIO THERAPEUTICS, INC.
  • HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
    Publication number: 20130023543
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: September 25, 2012
    Publication date: January 24, 2013
    Applicant: Aerpio Therapeutics Inc.
    Inventors: Jeffrey Lyle Gray, Kande K.D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE
    Publication number: 20130023542
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Application
    Filed: September 25, 2012
    Publication date: January 24, 2013
    Applicant: Aerpio Therapeutics Inc.
    Inventor: Aerpio Therapeutics Inc.
  • Human protein tyrosine phosphatase inhibitors and methods of use
    Patent number: 8338615
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: December 25, 2012
    Assignee: Aerpio Therapeutics Inc.
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Human protein tyrosine phosphatase inhibitors and method of use
    Patent number: 8329916
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: December 1, 2011
    Date of Patent: December 11, 2012
    Assignee: Aerpio Therapeutics Inc.
    Inventors: Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier, Jeffrey Lyle Gray
  • Compositions and methods for treating colitis
    Patent number: 8309537
    Abstract: Disclosed herein are compositions and methods for treating colitis and other inflammatory bowel diseases, inter alia, indeterminate colitis, Crohn's disease, irritable bowel syndrome and ischemic colitis.
    Type: Grant
    Filed: November 5, 2010
    Date of Patent: November 13, 2012
    Assignee: Aerpio Therapeutics Inc.
    Inventors: Joseph H. Gardner, Robert Shalwitz
  • Human protein tyrosine phosphatase inhibitors and methods of use
    Patent number: 8258311
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising said human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: November 23, 2009
    Date of Patent: September 4, 2012
    Assignee: Aerpio Therapeutics Inc.
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier
  • Human protein tyrosine phosphatase inhibitors and methods of use
    Patent number: 8188125
    Abstract: The present disclosure relates to compounds effective as human protein tyrosine phosphatase beta (HPTP-?) inhibitors thereby regulating angiogenesis. The present disclosure further relates to compositions comprising one or more human protein tyrosine phosphatase beta (HPTP-?) inhibitors, and to methods for regulating angiogenesis.
    Type: Grant
    Filed: May 18, 2009
    Date of Patent: May 29, 2012
    Assignee: Aerpio Therapeutics Inc.
    Inventors: Jeffrey Lyle Gray, Kande K. D. Amarasinghe, Cynthia Monesa Clark, Ryan Matthew Nichols, Matthew B. Maier